A study to evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants with Dyslipidaemia

Trial Identifier: D7960C00008
Sponsor: AstraZeneca
Start Date: December 2024
Primary Completion Date: June 2027
Study Completion Date: June 2027
Condition: Heart, Blood & Circulatory - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
CN Baotou, CN, 14010
CN Beijing, CN, 100029
CN Beijing, CN, 100050
CN Bengbu, CN, 233004
CN changchun, CN, 130021
CN Changchun, CN, 130033
CN Changde, CN, 415003
CN changsha, CN, 410015
CN Changzhou, CN, 272100
CN Chengdu, CN, 610000
CN Chongqing, CN, 402260
CN Deyang, CN, 618000
CN Guangzhou, CN, 510220
CN Guangzhou, CN, 510100
CN Hengyang, CN, 421001
CN Heze, CN, 274099
CN Linhai, CN, 317000
CN Luoyang, CN, 471000
CN Nanchang, CN, 330009
CN Nanchong, CN, 637900
CN Nanjing, CN, 210009
CN Pingxiang, CN, 337055
CN sanya, CN, 572000
CN Shanghai, CN, 200032
CN Shanghai, CN, 310000
CN Shanghai, CN, 200120
CN Siping, CN, 136000
CN Taiyuan, CN, 030024
CN Tianjin, CN, 300457
CN Wuhan, CN, 430030
CN Wuhan, CN, 430010
CN Wuhan, CN, 430060
CN Xi'an, CN, 710068
CN Xianyang, CN, 750004
CN Yinchuan, CN, 750004
CN Zigong, CN, 643021
HK Hong Kong, HK
HK Hong Kong, HK, 999077
HK Shatin, HK, 00000